These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2770061)

  • 21. [Reversal of experimental cerebral vasospasm by neuropeptides].
    Nozaki K
    Nihon Geka Hokan; 1990 Jan; 59(1):55-67. PubMed ID: 2130769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of dilazep on experimental vasospasm--evaluation of angiographical vasospasm and cerebral blood flow].
    Yamakawa K; Sasaki T; Saito I; Takakura K
    No To Shinkei; 1990 Jul; 42(7):669-73. PubMed ID: 2223263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene transfer of extracellular superoxide dismutase failed to prevent cerebral vasospasm after experimental subarachnoid hemorrhage.
    Yamaguchi M; Zhou C; Heistad DD; Watanabe Y; Zhang JH
    Stroke; 2004 Nov; 35(11):2512-7. PubMed ID: 15472087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subarachnoid hemorrhage and cerebrovascular spasm. Morphological study of intracranial arteries based on animal experiments and human autopsies.
    Eldevik OP; Kristiansen K; Torvik A
    J Neurosurg; 1981 Dec; 55(6):869-76. PubMed ID: 7299462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of basilar artery diameter in dogs: CT evaluation correlated with arteriography.
    Ho PS; Lee CC; Wang JY; Wang YC; Lin SZ; Chen FH; Chen JL
    Neuroradiology; 1988; 30(3):239-44. PubMed ID: 3405412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage.
    Ohkuma H; Parney I; Megyesi J; Ghahary A; Findlay JM
    J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A model for intracranial vasospasm in subarachnoid hemorrhage].
    Jin Y; Proust F; Rabehenoina A; Seigneur N; Creissard P; Tadie M
    Neurochirurgie; 1991; 37(1):44-9. PubMed ID: 2017293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
    Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
    Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of inflammation in experimental cerebral vasospasm.
    Peterson JW; Kwun BD; Hackett JD; Zervas NT
    J Neurosurg; 1990 May; 72(5):767-74. PubMed ID: 2182792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage.
    Zuccarello M; Marsch JT; Schmitt G; Woodward J; Anderson DK
    J Neurosurg; 1989 Jul; 71(1):98-104. PubMed ID: 2661744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats.
    Honda Y; Minato H; Fujitani B; Masuda Y; Hosoki K
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):699-706. PubMed ID: 9542720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prolonged spasm of the arteries of the base of the brain during experimental fibrinolysis in the subarachnoid space].
    Arutiunov A; Baron MA; Dobrovol'skiĭ GF; Kornienko VN; Maĭorova NA
    Vopr Neirokhir; 1975; (5):5-11. PubMed ID: 128201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog.
    Hirose H; Ide K; Sasaki T; Takahashi R; Kobayashi M; Ikemoto F; Yano M; Nishikibe M
    Eur J Pharmacol; 1995 Apr; 277(1):77-87. PubMed ID: 7635177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
    Sasaki T; Wakai S; Asano T; Takakura K; Sano K
    J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posttreatment with adenovirus-mediated gene transfer of calcitonin gene-related peptide to reverse cerebral vasospasm in dogs.
    Satoh M; Perkins E; Kimura H; Tang J; Chun Y; Heistad DD; Zhang JH
    J Neurosurg; 2002 Jul; 97(1):136-42. PubMed ID: 12134904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral blood flow and somatosensory evoked potentials in dogs with experimental vasospasm caused by double injection.
    Miyamoto Y; Matsuda M
    Nihon Geka Hokan; 1991 Sep; 60(5):289-98. PubMed ID: 1820002
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence of the role of hemolysis in experimental cerebral vasospasm.
    Peterson JW; Roussos L; Kwun BD; Hackett JD; Owen CJ; Zervas NT
    J Neurosurg; 1990 May; 72(5):775-81. PubMed ID: 2324801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of sympathetic nerve and vasoactive amines in experimental cerebral vasospasm in dogs (author's transl)].
    Mabe H
    No Shinkei Geka; 1978 Jun; 6(6):555-61. PubMed ID: 673135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
    Alexander E; Black PM; Liszczak TM; Zervas NT
    J Neurosurg; 1985 Dec; 63(6):949-58. PubMed ID: 4056908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered cerebrovascular CO2 reactivity following subarachnoid hemorrhage in cats.
    Diringer MN; Kirsch JR; Hanley DF; Traystman RJ
    J Neurosurg; 1993 Jun; 78(6):915-21. PubMed ID: 8487074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.